Log In
Print
BCIQ
Print
Print this Print this
 

PBS1101-1104

  Manage Alerts
Collapse Summary General Information
Company Perle Bioscience Inc.
DescriptionHuman beta regeneration agent for diabetes (BRAD) peptides for the generation of new insulin-producing beta cells from ductal progenitor cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today